ENvue Medical (FEED) Cash from Operations (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.14% |
| Dec 31, 2025 | -35.84% |
| Sep 30, 2025 | 41.77% |
| Jun 30, 2025 | -151.90% |
| Mar 31, 2025 | -145.07% |
| Dec 31, 2024 | 34.45% |
| Sep 30, 2024 | -51.18% |
| Jun 30, 2024 | 4.49% |
| Mar 31, 2024 | -17.92% |
| Dec 31, 2023 | 28.01% |
| Sep 30, 2023 | 44.51% |
| Jun 30, 2023 | -2.42% |
| Mar 31, 2023 | 9.84% |
| Dec 31, 2022 | 32.23% |
| Sep 30, 2022 | 1.75% |
| Jun 30, 2022 | -14.82% |
| Mar 31, 2022 | -101.74% |
| Dec 31, 2021 | -36.12% |
| Sep 30, 2021 | 66.91% |
| Jun 30, 2021 | -100.84% |
| Mar 31, 2021 | 27.62% |
| Dec 31, 2020 | -89.64% |
| Sep 30, 2020 | -43.89% |
| Jun 30, 2020 | 46.03% |
| Mar 31, 2020 | 13.28% |
| Dec 31, 2019 | 7.28% |
| Sep 30, 2019 | -40.53% |
| Jun 30, 2019 | 15.47% |
| Mar 31, 2019 | -6.36% |
| Dec 31, 2018 | -10.54% |
| Sep 30, 2018 | 20.70% |
| Jun 30, 2018 | -15.92% |
| Mar 31, 2018 | -11.15% |
| Dec 31, 2017 | -61.49% |
| Sep 30, 2017 | 6.03% |
| Jun 30, 2017 | -26.91% |
| Mar 31, 2017 | 4.93% |
| Dec 31, 2016 | -59.55% |
| Sep 30, 2016 | 44.14% |
| Jun 30, 2016 | -32.04% |
| Mar 31, 2016 | 4.74% |
| Dec 31, 2015 | -43.94% |
| Sep 30, 2015 | 50.84% |
| Jun 30, 2015 | -79.60% |
| Mar 31, 2015 | -21.05% |
| Dec 31, 2014 | 7.49% |
| Sep 30, 2014 | -16.59% |
| Jun 30, 2014 | -45.86% |